logo

AXNX(Delisted)

AxonicsยทNASDAQ
--
--(--)

AXNX Profile

Axonics, Inc.

A global medical technology company that developing novel products for bladder and bowel dysfunction

--
03/02/2012
10/31/2018
NASDAQ Stock Exchange
797
12-31
Common stock
26 Technology Drive, Irvine, California 92618
--
Axonics, Inc., was incorporated in Delaware on March 2, 2012. The Company is a global medical technology company that is developing and commercializing new products for adults with bladder and bowel dysfunction, including: (i) implantable SNM systems for the treatment of urinary urgency incontinence (UUI) and urinary urgency frequency (UUF), Collectively referred to as overactive bladder (OAB), fecal incontinence (FI) and non-obstructive urinary retention (UR); (ii) urethral fillers (Bulkamin) for the treatment of stress urinary incontinence (SUI) in women.